Geron Corporation (GERN) Reports 2010 Second Quarter Financial Results and Events
7/30/2010 10:04:51 AM
More...
|
Geron Corporation (GERN) Gets Human Trial Nod For Spinal Cord Therapy; FDA Lifts Clinical Hold On Human Trial Application
7/30/2010 7:00:27 AM
More...
|
Geron Announces Conference Call to Discuss Financial Results for the 2010 Second Quarter
7/27/2010 7:42:22 AM
More...
|
Geron Corporation (GERN) Initiates Randomized Phase 2 Clinical Trial of Imetelstat in Non-Small Cell Lung Cancer
7/19/2010 9:53:13 AM
More...
|
Geron Corporation (GERN) Provides Update on Telomerase Activation Program
7/15/2010 9:18:29 AM
More...
|
Geron Corporation (GERN) Presents Clinical Data on Its Telomerase Inhibitor Drug in Breast Cancer at American Society of Clinical Oncology
6/7/2010 11:18:42 AM
More...
|
Geron Corporation (GERN) Appoints Hoyoung Huh and Robert Spiegel to Its Board of Directors
5/20/2010 10:08:39 AM
More...
|
Geron Corporation (GERN) Announces Positive Data on Its Small Molecule Telomerase Activator in Model of Idiopathic Pulmonary Fibrosis
5/19/2010 9:39:17 AM
More...
|
Geron Corporation (GERN) to Present at the Rodman & Renshaw Annual Global Healthcare Conference
5/14/2010 10:20:20 AM
More...
|
Geron Corporation (GERN) Announces Positive Study Data on GRNCM1
5/13/2010 1:36:18 PM
More...
|
|